Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

In a groundbreaking development for neurological care, scientists have unveiled an artificial intelligence-powered blood test that has the potential to detect Parkinson’s disease years before ...

A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...

Deep brain stimulation (DBS) has shown remarkable therapeutic benefits for patients with otherwise treatment-resistant movement and affective disorders, such as chronic pain, Parkinson's disease ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers at Oregon Health & Science University (OHSU) are leading a study looking at a possible link between thrashing sleep and Parkinson's disease. Veterans diagnosed ... adults willing to ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

GW Hospital is proud to be the first adult-care hospital in the metropolitan Washington–Northern Virginia region to add MRI-guided ... tremor and Parkinson’s Disease a less invasive approach ...